PCSK6: The Endogenous PAR-1 Agonist Driving Pulmonary Fibrosis?
Am J Respir Crit Care Med
.
2023 Jun 15;207(12):1643-1644.
doi: 10.1164/rccm.202303-0355LE.
Authors
C Arnold Spek
1
2
,
JanWillem Duitman
3
4
5
Affiliations
1
Center for Experimental and Molecular Medicine.
2
Cancer Biology and Immunology, Cancer Center Amsterdam, Amsterdam, the Netherlands; and.
3
Department of Pulmonary Medicine, and.
4
Department of Experimental Immunology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.
5
Amsterdam Infection & Immunity, Inflammatory Diseases, Amsterdam, the Netherlands.
PMID:
36927336
PMCID:
PMC10273102
DOI:
10.1164/rccm.202303-0355LE
No abstract available
Publication types
Letter
Comment
MeSH terms
Cells, Cultured
Fibrosis
Humans
Proprotein Convertases
Pulmonary Fibrosis* / drug therapy
Serine Endopeptidases
Substances
Serine Endopeptidases
PCSK6 protein, human
Proprotein Convertases